Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moviprep Mode of Action in Constipation and Healthy Volunteers
NCT01622972Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Sep 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of macrogol in functional constipation (FC) and irritable bowel syndrome (IBS) (3 arms), sponsored by University of Nottingham. Primary endpoint: Area Under Curve (AUC) Small Bowel Water Content. Started Sep 2011; status: completed.
02
Drugs
macrogol
03
Conditions
functional constipation (FC)irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01622972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01622972.